Mapping antifungal drug resistance in Candida albicans by genomic approaches
Candida albicans is the leading cause of life-threatening invasive fungal infections with mortality rates approaching 40%, despite treatment. Resistance to the commonly used azoles is increasing and alternative antifungals, such as amphotericin B or echinocandins, increase the cost of antifungal the...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2024
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10773/33030 |
| País: | Portugal |
| Oai: | oai:ria.ua.pt:10773/33030 |